Signature Estate & Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69M Buy
57,559
+303
+0.5% +$310K 1.24% 22
2026
Q1
$52.7M Sell
57,256
-15,323
-21% -$15.5M 1.07% 23
2025
Q4
$78M Sell
72,579
-271
-0.4% -$259K 1.57% 17
2025
Q3
$55.6M Buy
72,850
+17,417
+31% +$13M 1.19% 22
2025
Q2
$43.2M Buy
55,433
+36,923
+199% +$28.7M 1% 23
2025
Q1
$15.3M Buy
18,510
+17,190
+1,302% +$14.3M 0.4% 37
2024
Q4
$1.02M Buy
1,320
+42
+3% +$34.8K 0.03% 211
2024
Q3
$1.13M Buy
1,278
+61
+5% +$54.8K 0.03% 185
2024
Q2
$1.1M Buy
+1,217
New +$974K 0.03% 184

Other funds holding LLY

Signature Estate & Investment Advisors's LLY Position: Q2 2026 in Review

Signature Estate & Investment Advisors increased its Eli Lilly (LLY) stake by 0.53% in Q2 2026, buying an estimated $310K and bringing the position to 57,559 shares worth $69M. The position accounts for 1.24% of the portfolio, ranked #22.

Signature Estate & Investment Advisors first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. The position peaked at $78M in Q4 2025. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Signature Estate & Investment Advisors held 57,559 shares of Eli Lilly worth $69M as of Q2 2026.
  • Signature Estate & Investment Advisors bought 303 Eli Lilly shares in Q2 2026, an estimated $310K.
  • Eli Lilly made up 1.24% of Signature Estate & Investment Advisors's portfolio in Q2 2026, its #22 holding.
  • Signature Estate & Investment Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • Signature Estate & Investment Advisors's Eli Lilly position peaked at $78M in Q4 2025.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.